- ￥5571.75
- ENZO
- 美国
- ENZ-ABS104-0100
- 2025年07月15日
- human
企业认证
相关产品推荐更多 >
![Geminin antibody [2H7]](https://img1.dxycdn.com/2023/0711/451/6106825198874858761-14.jpg!wh200)
![DDX19A antibody [C1C3]](https://img1.dxycdn.com/2023/0711/255/2344116916935858761-14.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 形态：
液体
- 保存条件：
-20°C
- 克隆性：
多克隆
- 适应物种：
human
- 抗体英文名：
Lymphatic endothelial marker (human) monoclonal antibody (D2-40)
- 抗体名：
Lymphatic endothelial marker (human) monoclonal antibody (D2-40)
- 规格：
1*100µl
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验YKL-40: A Novel Marker Shared by Chronic Inflammation and Oncogenic Transformation
YKL-40, a member of ‘mammalian chitinase-like proteins’, is secreted by macrophages, neutrophils, chondrocytes, endothelial-, vascular smooth muscle-, and cancer cells. High serum YKL-40 is a biomar-ker of poor prognosis in patients
【翻译】Development trends for monoclonal antibody cancer therapeutics
). However, since 2000, humanized and human mAbs have been entering clinical study at approximately the same rate (4.3 versus 4.5 mAbs per year, respectively). Figure 1 | Categories of monoclonal antibody cancer therapeutics entering clinical study during 1980–1989
The production of monoclonal antibody by hybridoma
The production of monoclonal antibody by hybridoma fusion: Immortalization of sensitized B lymphocytes from immune mice. Overview
技术资料暂无技术资料 索取技术资料
